BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11979860)

  • 1. [Proton pump inhibitors: Omeprazole].
    Iwasaki A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():633-9. PubMed ID: 11979860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H; Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract]   [Full Text] [Related]  

  • 3. [New triple therapy for Helicobacter pylori infection].
    Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():414-9. PubMed ID: 11979817
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
    Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():627-31. PubMed ID: 11979859
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proton pump inhibitors: Rabeprazole].
    Yoshino J
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():645-9. PubMed ID: 11979863
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
    Nagahara A; Miyazaki A; Miwa H; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():435-8. PubMed ID: 11979822
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
    Ohkusa T; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():431-4. PubMed ID: 11979821
    [No Abstract]   [Full Text] [Related]  

  • 8. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy.
    Mégraud F
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S35-7; discussion S43-5. PubMed ID: 10503821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [H. pylori eradication therapy and natural history of peptic ulcer].
    Haruma K; Kamada T; Kusunoki H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():49-53. PubMed ID: 11979833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Eradication of Helicobacter pylori].
    Herszényi L
    Orv Hetil; 2003 Oct; 144(40):1991-2. PubMed ID: 14626641
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of clarithromycin in eradicating Helicobacter pylori.
    Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
    J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H; Kato M; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
    Sugano K
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():32-7. PubMed ID: 11989260
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
    Inoue K; Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.